Krystal Biotech, Inc. (KRYS)
359.37
+7.91
(+2.25%)
USD |
NASDAQ |
Aug 31, 16:00
359.37
0.00 (0.00%)
After-Hours: 20:00
Krystal Biotech Cash from Operations (TTM) : 272.34M for June 30, 2026
Cash from Operations (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 272.34M |
| March 31, 2026 | 250.28M |
| December 31, 2025 | 200.86M |
| September 30, 2025 | 176.20M |
| June 30, 2025 | 195.40M |
| March 31, 2025 | 138.50M |
| December 31, 2024 | 123.42M |
| September 30, 2024 | 63.34M |
| June 30, 2024 | -16.74M |
| March 31, 2024 | -46.76M |
| December 31, 2023 | -88.80M |
| September 30, 2023 | -103.90M |
| June 30, 2023 | -102.36M |
| March 31, 2023 | -111.23M |
| December 31, 2022 | -100.57M |
| September 30, 2022 | -99.14M |
| June 30, 2022 | -86.71M |
| March 31, 2022 | -53.78M |
| December 31, 2021 | -47.94M |
| September 30, 2021 | -35.06M |
| Date | Value |
|---|---|
| June 30, 2021 | -34.57M |
| March 31, 2021 | -29.51M |
| December 31, 2020 | -26.08M |
| September 30, 2020 | -25.10M |
| June 30, 2020 | -22.58M |
| March 31, 2020 | -21.72M |
| December 31, 2019 | -18.71M |
| September 30, 2019 | -15.18M |
| June 30, 2019 | -12.88M |
| March 31, 2019 | -10.29M |
| December 31, 2018 | -9.445M |
| September 30, 2018 | -8.054M |
| June 30, 2018 | -7.212M |
| March 31, 2018 | -6.002M |
| December 31, 2017 | -3.89M |
| September 30, 2017 | -2.624M |
| June 30, 2017 | -1.837M |
| March 31, 2017 | -1.568M |
| December 31, 2016 | -1.311M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (TTM) Benchmarks
| Marker Therapeutics, Inc. | -9.756M |
| TG Therapeutics, Inc. | 17.88M |
| Cytokinetics, Inc. | -555.45M |
| ADMA Biologics, Inc. | 136.72M |
| Alnylam Pharmaceuticals, Inc. | 885.89M |